Comera Life Sciences Holdings, Inc. announced that it has entered into agreement for a private placement of 2,406,242 units at an issue price of $1.48 per unit for proceeds of $3,561,238.16 led by existing investors Charles Cherington and David Soane on January 2, 2023. The transaction will include participation from existing investors John Halpern, Curtis Huff, Edward Bennett, Roopom Banerjee, Barbara Finck, Kirsten Flowers, Stuart Randle, Rev. Dr. James Sherblom and Edward Sullivan, members of the company's board of directors.

Each unit consists of one common share and one five-year warrant to purchase two shares of the Company's common shares at an exercise price of $1.23 per share. The company also issued warrants to purchase 405,402 shares of the company to Soane Family Trust, Alexander V. Soane 2019 Irrevocable Trust and Nicholas V. Soane 2019 Irrevocable Trust. The securities to be issued are pursuant to Regulation D.